Recent Quarter Total Invested
$32.27 M
Recent Quarter Institutional Ownership Percentage
3.08%
Total Invested of Last Quarter
$18.81 M
Ownership Percentage of Last Quarter
1.62%
Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 750,000 | $29.24 M | 0.00% | 2.79% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 08/16/2024 | 25,627 | $999,197 | 0.45% | 0.10% |
| OPTIVER HOLDING B.V. | 08/14/2024 | 22,336 | $870,881 | 781.45% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 20,200 | $787,598 | -11.40% | 0.08% |
| UBS GROUP AG | 08/14/2024 | 10,756 | $419,376 | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 08/14/2024 | 8,500 | $331,415 | 466.67% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 6,400 | $249,536 | -33.33% | 0.02% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 08/14/2024 | 6,000 | $320,042 | 100.00% | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 5,397 | $210,429 | -47.48% | 0.02% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 1,500 | $58,485 | -60.11% | 0.01% |
| MORGAN STANLEY | 08/14/2024 | 919 | $35,838 | -84.65% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 08/12/2024 | 877 | $34,195 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 656 | $25,577 | -37.04% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 07/23/2024 | 500 | $19,495 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 255 | $9,942 | -76.90% | 0.00% |
| RHUMBLINE ADVISERS | 08/01/2024 | 202 | $7,873 | 23.17% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 08/13/2024 | 125 | $4,806 | 100.00% | 0.00% |
| COLONIAL TRUST ADVISORS | 08/14/2024 | 105 | $4,094 | 0.00% | 0.00% |
| MISSOURI TRUST & INVESTMENT CO | 08/14/2024 | 35 | $1,365 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 17 | $663 | -76.39% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 08/09/2024 | 14 | $546 | 100.00% | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 0 | $0 | -100.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 07/10/2024 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Calliditas Therapeutics AB (publ)institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CALT shares?
During the previous two years, 27 institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ). The most heavily invested institutionals were:
BVF INC/IL: 750,000
IRONWOOD INVESTMENT MANAGEMENT LLC: 25,627
Optiver Holding B.V.: 22,336
UBS Group AG: 10,756
PenderFund Capital Management Ltd.: 6,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 5,397
-
What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors?
3.08% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors.
-
How much institutional buying is happening at CALT ?
Institutional investors have bought a total of 825,339 shares in the last 24 months. This purchase volume represents approximately $33.01 M in transactions.